AZN — ASTRAZENECA PLC catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

17 verified catalyst event(s) for ASTRAZENECA PLC (ticker AZN). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-11-05 — A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prost · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-11-05 in 1d ESTIMATED	READOUT A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metast Phase 1/2 · Prostate Cancer	AZN ASTRAZENECA PLC	AZD9750, AZD5305	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-11-17 in 13d ESTIMATED	READOUT AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Phase 2 · Gastric Cancer, Gastroesophageal Junction Cancer	AZN ASTRAZENECA PLC	AZD0901, 5-Fluorouracil, Leucovorin, l-l	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-11-24 in 20d ESTIMATED	READOUT Study of AZD0754 in Participants With Metastatic Prostate Cancer Phase 1/2 · Metastatic Prostate Cancer	AZN ASTRAZENECA PLC	AZD0754, AZD2287	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-10 in 1mo ESTIMATED	READOUT A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Ba Phase 2 · Chronic Kidney Disease and Hypertension	AZN ASTRAZENECA PLC	Baxdrostat/dapagliflozin, Baxdrostat/Pla	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-23 in 2mo ESTIMATED	READOUT A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim Phase 3 · Asthma	AZN ASTRAZENECA PLC	Benralizumab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-31 in 2mo ESTIMATED	READOUT Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With D Phase 3 · Cancer	AZN ASTRAZENECA PLC	Durvalumab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-04 in 2mo ESTIMATED	READOUT A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH Phase 3 · Heterozygous Familial Hypercholesterolaemia	AZN ASTRAZENECA PLC	AZD0780	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-06 in 2mo ESTIMATED	READOUT Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) Phase 3 · Systemic Sclerosis, Scleroderma	AZN ASTRAZENECA PLC	Anifrolumab (blinded), Anifrolumab (unbl	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-11 in 2mo ESTIMATED	READOUT A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osime Phase 3 · Metastatic Non-small Cell Lung Cancer	AZN ASTRAZENECA PLC	Dato-DXd, Osimertinib, Pemetrexed, Carbo	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-11 in 2mo ESTIMATED	READOUT A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clin Phase 3 · Cardiovascular Disease	AZN ASTRAZENECA PLC	AZD0780	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-13 in 2mo ESTIMATED	READOUT A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rh Phase 3 · Chronic Rhinosinusitis With Nasal Polyps	AZN ASTRAZENECA PLC	Tezepelumab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-03 in 3mo ESTIMATED	READOUT Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therap Phase 4 · Asthma	AZN ASTRAZENECA PLC	Albuterol and budesonide inhalation aero	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-11 in 3mo ESTIMATED	READOUT A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Parti Phase 2 · Sepsis, Acute Kidney Injury	AZN ASTRAZENECA PLC	AZD4144	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-18 in 4mo ESTIMATED	READOUT Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflo Phase 3 · Chronic Kidney Disease With High Proteinuria	AZN ASTRAZENECA PLC	Zibotentan/Dapagliflozin, Dapagliflozin	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-22 in 4mo ESTIMATED	READOUT Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With O Phase 3 · Cancer	AZN ASTRAZENECA PLC	Osimertinib	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-23 in 4mo ESTIMATED	READOUT Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus N Phase 3 · Lupus Nephritis	AZN ASTRAZENECA PLC	Anifrolumab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-03-08 in 4mo ESTIMATED	READOUT A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase Phase 1/2 · Staphylococcus Aureus	AZN ASTRAZENECA PLC	AZD7760	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change